Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F13HR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,382
Award facts
- Contract value 100% obligated
- $15,381.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,381.77 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the breadth of pharmaceutical products supplied through the DLA's medical procurement network.
This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves critical federal healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government medical systems. The parent IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, demonstrating the company's established capability to fulfill federal medical procurement requirements through competitive contracting processes.
Quick answers
Who was awarded contract SPE2DR26F13HR?
SPE2DR26F13HR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F13HR worth?
The government has obligated $15,382 on SPE2DR26F13HR.
Is contract SPE2DR26F13HR an order under another contract?
Yes. SPE2DR26F13HR is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13HR competed?
The extent of competition for SPE2DR26F13HR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award